NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/08/2022
Back to search
Official data from USPTO
ALIMENTIV
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Quick snapshot
ST13
US500000090381096Class
9, 35, 42, 44, 45
Filing
90381096
Registration
6891764
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
33
Latest update
11/08/2022
Trademark type
Combined
Nice classes
9, 35, 42, 44, 45
Filing date
12/14/2020
Registration date
11/08/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/08/2022
Last transaction
11/08/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
First use anywhere
10/21/2020
First use in commerce
10/21/2020
Drawing code
3
Owner type
03
Owner location
London, Ontario, CA
Examiner
YOUNG, SKYE
Law office
M80
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the word "ALIMENTIV" in stylized form with the letter "T" appearing with four connected circles at the top.
Holders and representatives
Holders
Alimentiv Inc.
Representatives
Kathryn E. Garipay OLSON & CEPURITIS, LTD.
Technical classification
Nice Classes
Class 9Class 35Class 42Class 44Class 45
Vienna Codes
No Vienna codes available.
Goods and services
Class 9
Computersperipheral hardware componentsblank external hard drivesblank flash drivesvideo cables; video capture devicessignal processorsvideo receivers and video recorders for converting signals from endoscopy machines to USB for storing on computers; Recorded video recording softwaredownloadable video recording software configured according to study protocol requirements for receivingstoring and securely sending clinical study dataobtained from using imaging endoscopic proceduresover the Internet to a secure website
Class 35
Business project management servicesproject management of clinical studiesrecruitment and selection of clinical study sites and investigatorsmanagement of clinical study sites and clinical monitoringmanaging relationships between vendors and subcontractorsorganization and planning of meetingsworkshops and events; Records management servicesdocument indexing for othersspecificallycoordinating and controlling flow of electronic and paper documents; Data management services for use in pharmaceutical drug developmentpreparation of Case Report Forms (CRFs)Collection and compilation of information into computer databases in the field of clinical studies; Compilation and provision of statistical and biostatistical information; Medical coding services for others in the nature of coding clinical trial data for purposes of medical science and regulatory review and approvals
Class 42
Technical writingmedical writing services for developing medical protocolsclinical study reportsinvestigator brochuressafety reportsinformed consent formsmeeting abstractspostersmanuscriptsstudy chartsmanuals and literature reviews; Providing an Internet website portal featuring clinical study and clinical trial management system tools; Electronic storage of files and documentssecure storage of electronic and paper documents; File sharing servicesproviding a website featuring technology enabling users to upload and download electronic filescomplete and inspection-ready trial management files; Electronic storage services for archiving databasesimages and other electronic data in the field of trial management files (TMF)TMF setuparchiving and management of TMP files through lifecycle of clinical study; Conducting scientific researchbiostatistics and statistical programmingprotocol development of sample size and power calculationsrandomization schedulesstatistical analysis plansstatistical programming and validation in statistical analysis systemstatistical analysesinterpretation and reporting of data for clinical trial reports and publicationsstatistical and strategic consulting for product developmentinterim analysis for early decision-makingdatabase integrationNew Drug Application (NDA) ready data listingsregulatory submission compliant datasetsthought leadership and operational experience with study data tabulation model and analysis data model regulatory submission standardsintegrated safety and efficacy summariesadaptive design consulting and simulation supporttranslational research support data monitoring board management and support; Medical research servicesmedical monitoring and investigator site monitoring in the field of medical review of clinical study materialspreparation of medical monitoring and safety planscontinuous trial oversight via patient level and safety data reviewsubject eligibility support for investigatorsmedical support to sites and study teams for interpretation of study protocolconsultation on potential safety issues and medical concerns and 24/7 medical monitor coverage; Pharmaceutical drug development services in the field of drug safetyspecificallyprocessing adverse events from clinical trialspreparing Development Safety Update Reports (DSURs) and other aggregate reportsperforming signal detection and benefit-risk assessmentspreparing safety management plans and preparing medical monitoring plans; Providing quality assurance services in the field of clinical trialsquality assistance documentationsuch as Standard Operating Procedures (SOPs) and work instructionsinternal system reviewssite auditsvendor assessments; Medical research services in the field of pharmacologydose simulationselection and optimizationselection of biomarkers and endpointsoptimization of trial designpopulation pharmacokinetic and pharmacodynamic modelingexposure response modeling; Medical research services in the field of translational medicineimmunohistochemistryflow cytometrytranscriptomicsproteomicsmicrobiome study; Providing medical and scientific research information in the field of clinical trialsthe design of clinical trials and outcome measures for studying human diseasesfor studying or testing drugsdevices or methods of medical treatment on humans in relation to diseases; Conducting clinical trials for others which study human diseasesstudy or test drugsdevices or methods of medical treatment on humans in relation to diseases; Custom computer programming of imaging adjudication and computer systems integration of eligibility data with Interactive Response Technology (IRT); Computer database design and implementation for data collectiondata storagedata managementdata analysisdata validation for use in pharmaceutical drug development; Compilation and provision of clinical study datacompiling data for research purposes in the field of medical science and medical consultancy
Class 44
Medical imaging services; Medical diagnostic testingmonitoring and reporting services; Medical imaging serviceselectronic medical imaging support services for use in assessing patient health in clinical trialsreviewing and scoring electronic medical imagesincluding video imagesof patients supplied by others; Medical imaging serviceshistopathology support services for reviewing and scoring tissue sample images provided by others; Consulting services in the field of medical imagingmagnetic resonance support services for reviewing and scoring magnetic resonance images provided by others; Medical servicesendoscopy support services in the field of reviewing and scoring endoscopic images provided by others
Class 45
Regulatory submission managementassisting others with preparing and filing applications for new drugs with government regulatory bodiessubmission planning and life cycle management of clinical trial applications to Competent AuthoritiesEthics Committees and Regulatory Agenciespre-approval submissionssubmission of supplementsamendments and variations applicationssubmission publishing and dossier compilation in electronic common technical document or common technical document formatsannual reportspaper submissions management and submission archival
Publications
History of USPTO decisions and trademark events.
33 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
11/08/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/23/2022
PUBO
PUBLISHED FOR OPPOSITION
08/23/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/03/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/16/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/06/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/06/2022
ALIE
ASSIGNED TO LIE
07/06/2022
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
06/21/2022
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
06/13/2022
GNSL
LETTER OF SUSPENSION E-MAILED
06/13/2022
CNSL
SUSPENSION LETTER WRITTEN
06/13/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
06/13/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
06/13/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
06/13/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
06/13/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/19/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/18/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/18/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/07/2021
GNRT
NON-FINAL ACTION E-MAILED
12/07/2021
CNRT
NON-FINAL ACTION WRITTEN
12/07/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/29/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/28/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/28/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/15/2021
GNRT
NON-FINAL ACTION E-MAILED
06/15/2021
CNRT
NON-FINAL ACTION WRITTEN
06/15/2021
DOCK
ASSIGNED TO EXAMINER
06/04/2021
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
02/23/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/22/2021
NWAP
NEW APPLICATION ENTERED
12/17/2020
Continuous trademark protection
Get notified about every new filing that threatens ALIMENTIV or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.